TRAVERE THERAPEUTICS, INC.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 38.8M |
| FY2018 | 40.4M |
| FY2019 | 42.3M |
| FY2020 | 47.5M |
| FY2021 | 59.8M |
| FY2022 | 63.8M |
| FY2023 | 74.3M |
| FY2024 | 78.9M |
| FY2025 | 89.2M |
| FY2026 | 92.2M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 38.8M |
| FY2018 | 40.4M |
| FY2019 | 42.3M |
| FY2020 | 47.5M |
| FY2021 | 59.8M |
| FY2022 | 63.8M |
| FY2023 | 74.3M |
| FY2024 | 78.9M |
| FY2025 | 89.2M |
| FY2026 | 92.2M |